|Articles|August 10, 2022
Osmolality monitoring for UF/DF and CEX capture of mAbs from mammalian cell cultures (August 2022)
Author(s)Advanced Instruments
The goal of this paper is to introduce and support the use of osmolality in the Downstream Ultrafiltration/Diafiltration (UF/DF) process steps in the mAb workflow.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Transforming Clinical Bioanalysis for Manufacturing Scalability
2
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
3
Mastering Phase-Appropriate Characterization for Biologics Approval
4
Biomarker-Specific De Novo Assay Creation
5
